DEA Hearing July 2026: What the Outcome Means for Cannabis Operators

By Daniel Sabet · Cannabis CFO & Financial Advisor, GreenGrowth CPAs · 280E, Tax Strategy & Growth Planning · Los Angeles, CA  |  Published July 2026  |  Cannabis Advisory

The DEA administrative hearing on cannabis rescheduling concluded its testimony phase on July 15, 2026. This is an important regulatory milestone. However, it is not a decision, a verdict, or a rule change. The hearing built a factual record, and the ALJ, DEA Chief Administrative Law Judge Derek Julius, now reviews that record before issuing a recommendation. Crucially, that recommendation carries no legal deadline. After it arrives, the DEA Administrator reviews it and can accept, modify, or ignore it entirely. A final rule, if one comes, then faces a 30-day legal challenge window. Furthermore, multiple lawsuits challenging this process are already consolidated in a federal appeals court. The realistic timeline from hearing conclusion to any actual operator impact is 12 to 24 months, at the earliest.

DEA Hearing July 2026: At a Glance

• What happened: The DEA administrative hearing on broader cannabis rescheduling ran from June 29 to July 15, 2026, with a July 3 recess. DEA Chief ALJ Derek Julius presided over the testimony phase.
• What comes next: The ALJ issues a recommended decision. No deadline applies. After that, the DEA Administrator reviews the recommendation and issues a final rule. No deadline applies to that step either.
• Key structural issue: The DEA invited seven anti-rescheduling parties and zero pro-rescheduling parties to participate. Legal observers have flagged this as unprecedented in a major federal NPRM hearing and a potential source of further litigation.
• For medical operators: The April 22 order is in effect and the hearing changes nothing. Continue implementing post-rescheduling tax planning now.
• For adult-use operators: 280E continues to apply in full. Plan under current law. Do not build financial models around hearing outcomes that have not produced a final rule.
• GreenGrowth's role: We monitor the rescheduling process and advise cannabis clients on what actions belong on their planning list at each stage. Book a regulatory planning review →

What the June 29 Hearing Was About and What It Was Not

The June 29 hearing was a formal evidentiary proceeding under the Administrative Procedures Act. Its purpose was to build a factual record on whether marijuana more broadly, including adult-use cannabis, should move from Schedule I to Schedule III. It was not a trial in the conventional sense, and it did not produce a verdict. Instead, it gathered testimony and evidence that the ALJ now evaluates before issuing a recommended decision.

The One-Sided Participant Selection

A significant procedural development shapes how the hearing record should be read. The DEA selected seven participants and every one of them opposed cannabis reform. Organizations including NORML, the Drug Policy Alliance, and the American Trade Association for Cannabis and Hemp applied to participate and were rejected. The DEA's reasoning: supporters of rescheduling cannot be adversely affected by a rule they support, so they do not qualify as interested persons under federal regulations.

Legal observers have called this the first known instance of fully one-sided participant selection in a major federal NPRM hearing. Importantly, the ALJ himself noted that the government carries the burden of proof as the proponent of the proposed rule. As a result, the procedural setup creates its own legal vulnerability. Several ongoing lawsuits challenging the rescheduling process are consolidated in a federal appeals court, and this procedural issue may consequently become a significant point in that litigation.

Likely Outcomes and the Financial Implications of Each

The ALJ has three options after reviewing the hearing record. First, the ALJ can recommend that rescheduling proceed as proposed, moving marijuana as a whole to Schedule III. Second, the ALJ can recommend modifications, such as moving only specific categories or adding conditions. Third, the ALJ can recommend against rescheduling entirely. In all three scenarios, the DEA Administrator then makes the final call and can diverge from the recommendation.

Scenario 1: Full Rescheduling Recommended and Finalized

If the ALJ recommends full rescheduling and the DEA Administrator issues a final rule accordingly, 280E would stop applying to adult-use cannabis by its own terms. Operators would deduct their full operating expense base rather than only COGS. For a typical dispensary with $500,000 in annual SG&A, this represents approximately $175,000 in annual federal tax savings at a 35% rate. Additionally, credit profiles would improve, banking access would modestly expand, and acquisition multiples across the industry would likely rise.

Critically, this outcome still requires a final rule with an effective date. The IRS would need to issue implementing guidance similar to the transition rule announced for medical operators in April. Furthermore, given the one-sided hearing structure and ongoing litigation, legal challenges would almost certainly delay implementation. Even in the most favorable scenario, operators should plan for meaningful implementation lag.

Scenario 2: Partial Movement or No Change

If the ALJ recommends modifications or the DEA Administrator narrows the scope of any final rule, adult-use operators may continue facing 280E with no meaningful near-term change. In the no-change scenario, the current framework holds indefinitely and future relief would require congressional action or a new rulemaking cycle. Either way, planning conservatively under current law remains the right posture until a final rule is actually published.

What Should Cannabis Operators Do Now After the Hearing?

The right posture immediately following the hearing is conservative, incremental, and positioned to move quickly when the law actually changes. Preparation is valuable. Premature action based on anticipated outcomes, however, is not.

For Medical Cannabis Operators

The April 22 order is in effect regardless of what the ALJ recommends. Continue implementing post-rescheduling tax planning: recalculate Q3 and Q4 estimated payments, implement newly available deductions before December 31, and file protective refund claims for open prior years. None of these actions depend on the hearing outcome. The hearing does not affect the April 22 order for medical operators either positively or negatively in the near term. For more on these actions, see our cannabis advisory services.

For Adult-Use Cannabis Operators

280E still applies in full. Maintain current tax planning and compliance under existing law. Do not reduce estimated tax payments in anticipation of a rescheduling outcome that has not produced a final rule. The September 15 Q3 estimated payment deadline operates under current law. However, there is meaningful preparation work available now without changing any current-year tax position.

Build Your Three-Scenario Model Now

Start by building a three-scenario financial model: no change, partial rescheduling, and full rescheduling. For each scenario, calculate your effective tax rate, identify which entity structure decisions would change, and quantify the cash flow difference. None of this requires modifying your 2026 tax position. Consequently, all of it means you can act immediately when the law actually changes, rather than spending weeks rebuilding the analysis after a final rule arrives. For help building this model, see our cannabis tax compliance services.

Document Your Current 280E Position Rigorously

Regardless of license type or hearing outcome, every cannabis operator should maintain clean, well-documented 280E records now. When rescheduling does produce a final effective date for adult-use operators, the transition will be more straightforward for operators who kept rigorous expense segregation documentation. Operators with clean records will implement changes in days. Those with messy records will spend weeks reconstructing the foundation first.

Frequently Asked Questions